Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2011-08-16
2011-08-16
Desai, Anand (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C424S078170
Reexamination Certificate
active
07998925
ABSTRACT:
Methods for modification of tissue using covalent chemistry. Tissue can be modified through direct alkylation, reduction followed by alkylation, or oxidation followed by condensation to covalently attach small organic molecules or appropriately modified proteins. The modification can be spatially limited to desired regions of the tissue surface.
REFERENCES:
patent: 5821343 (1998-10-01), Keogh
patent: 5977252 (1999-11-01), Wagner et al.
patent: 6570040 (2003-05-01), Saxon et al.
patent: 6861211 (2005-03-01), Levy et al.
patent: 0 732 110 (1996-09-01), None
patent: WO 02/00685 (2002-01-01), None
Bank et al., Surface engineering of living myoblasts via selective periodate oxidation, Mar. 30, 2003, vol. 81, No. 7, pp. 800-808.
McFetridge et al. “Preparation of porcine carotid arteries for vascular tissue engineering applications”, Journal of Biomedical Materials Research Part A, vol. 70A, Issue 2, pp. 224-234 (Jun. 2004).
Hermanson, G. Bioconjugate Techniques, Academic Press, pp. 19-21, and 114-116 (1996).
De La Fuente EK, Dawson CA, Nelin LD, Bongard RD, McAuliffe TL, Merker MP. Biotinylation of membrane proteins accessible via the pulmonary circulation in normal and hyperoxic rats. Am J Physiol. Mar. 1997;272(3 Pt 1):L461-70.
Halfter W. Anterograde tracing of retinal axons in the avian embryo with low molecular weight derivatives of biotin. Dev Biol. Feb. 1987;119(2):322-35.
Hoya K, Guterman LR, Miskolczi L, Hopkins LN. A novel intravascular drug delivery method using endothelial biotinylation and avidin-biotln binding. Drug Deliv. Oct.-Dec. 2001;8(4):215-22.
Hoffman-Fezer G, Maschke H, Zeitler HJ, Gais P, Heger W, Ellwart J, Thierfelder S. Direct in vivo biotinylation of erythrocytes as an assay for red cell survival studies. Ann Hematol. Oct. 1991;63(4):214-7.
Partial International Search from the PCT dated Mar. 16, 2006.
Bank De P A et al: “Surface engineering of living myoblasts via selective periodate oxidation” Biotechnology and Bioengineering—Combinatorial Chemistry, Wiley, New York, NY, US, vol. 81, No. 7, Mar. 30, 2003, pp. 800-808.
Fabris F et al: “Labeling of Platelet Surface Glycoproteins With Biotin Derivatives” Thrombosis Research, Tarrytown, NY, US, vol. 66, No. 4, May 15, 1992, pp. 409-419.
Bayer E A et al: “Biocytin Hydrazide—A Selective Label for Sialic Acids, Galactose,and Other Sugars in Glycoconjugates Using Avidin-Biotin Technology” Analytical Biochemistry, Academic Press, New York, NY, US, vol. 170, No. 2, 1988, pp. 271-281.
Rando R R et al: “Labeling of Oxidized Cell Surface Membranes by Acyl Hydrazides” Biochimica et Biophysica Acta, vol. 557, No. 2, 1979, pp. 354-362.
Huestis W H: “Preliminary characterization of the acetylcholine receptor in human erythrocytes” Journal of Supramolecular and Cellular Biochemistry 1976, vol. 4, No. 3, 1976, pp. 355-365.
Karlin A et al: “The affinity labeling of partially purified acetylcholine receptor from electric tissue of Electrophorus” Proceedings of the National Academy of Sciences of the United States of America 1973, vol. 70, No. 12, 1973, p. 1.
Burns J A et al: “Selective reduction of disulfides by tris(2- carboxyethyl)phosphine” Journal of Organic Chemistry, American Chemical Society. Easton, US, vol. 56, No. 8, 1991, pp. 2648-2650.
European Patent Office, International Preliminary Report on Patentability, Application No. PCT/US2005/034991, Apr. 3, 2007.
European Patent Office, International Search Report, Application No. PCT/US2005/034991, Mar. 9, 2007.
European Patent Office, Communication Pursuant to Article 94(3) EPC, Application No. PCT/US2005/034991, Dec. 7, 2010.
Kane Robert R.
Perera Aruna
Baylor University
Desai Anand
Jackson Walker L.L.P.
LandOfFree
Spatially-defined modification of fresh tissue using... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Spatially-defined modification of fresh tissue using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spatially-defined modification of fresh tissue using... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2659445